Cristina Colarossi

21PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targetsEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 29, 2024
The Protective Role of Troxerutin (Trox) in Counteracting Anaplastic Thyroid Carcinoma (ATC) Progression.

Valentina Bova, Rossella Basilotta, Giovanna Casili

|Jun 19, 2024
ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic Interpretation.

Giuseppe Angelico, Giulio Attanasio, Lorenzo Colarossi

|Mar 28, 2024
Correction: Casili et al. Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC). Cancers 2023, 15, 2796.

Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza

|Sep 28, 2023
Interleukin-21 Influences Glioblastoma Course: Biological Mechanisms and Therapeutic Potential.

Alberto Repici, Alessio Ardizzone, Alessia Filippone

|Jun 28, 2023
Cancer in Migrants: A Population-Based Study in Italy.

Giulia Collatuzzo, Margherita Ferrante, Antonella Ippolito

|Jun 22, 2023
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC).

Giovanna Casili, Sarah Adriana Scuderi, Marika Lanza

Pageof 4

Frequent Collaborators

10 joint publications

Emanuela Esposito

9 joint publications

Salvatore Cuzzocrea

6 joint publications

Anna Paola Capra

5 joint publications

Raffella Giuffrida